Overview
Matthew Campbell is an Oncologist practicing medicine in Cary, North Carolina.
Dr. Campbell is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Familial Wilms Tumor 2.
He is actively involved in clinical research, co-authoring 4 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
210 Ashville Ave # 408, Cary, NC 27518
1155 Pressler St Unit 1374, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UT MD Anderson Cancer Center
Anthony Conley is an Oncologist practicing medicine in Cary, North Carolina. Dr. Conley is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Chondrosarcoma, Alveolar Soft Part Sarcoma, Liposarcoma, and Salpingo-Oophorectomy.
UT MD Anderson Cancer Center
Alessandra Ferrajoli is an Oncologist practicing medicine in Cary, North Carolina. Dr. Ferrajoli is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Aspiration.
UT MD Anderson Cancer Center
Michelle Fanale is an Oncologist practicing medicine in Cary, North Carolina. Dr. Fanale is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, T-Cell Lymphoma, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Matthew T. Campbell
How do I make an appointment with Dr. Matthew T. Campbell?
You can book an appointment with Dr. Matthew T. Campbell by calling their office at 713-792-6161. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Matthew T. Campbell a top-rated expert for Chromophobe Renal Cell Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthew T. Campbell is classified as an Distinguished expert for Chromophobe Renal Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Matthew T. Campbell specialize in?
While Dr. Matthew T. Campbell is a Oncology, they have specific expertise in Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Clear Cell Sarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Matthew T. Campbell participate in research or clinical trials?
Yes. Dr. Matthew T. Campbell has published 4 articles and abstracts on conditions like Chromophobe Renal Cell Carcinoma. You can view a list of Dr. Matthew T. Campbell's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Matthew T. Campbell accept my insurance?
Dr. Matthew T. Campbell accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 713-792-6161 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adrenal CancerDr. Campbell isDistinguished. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Campbell isDistinguished. Learn about Adrenocortical Carcinoma.
- Adult Soft Tissue SarcomaDr. Campbell isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Campbell isDistinguished. Learn about Bladder Cancer.
- ChoriocarcinomaDr. Campbell isDistinguished. Learn about Choriocarcinoma.
- Chromophobe Renal Cell CarcinomaDr. Campbell isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Campbell isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Campbell isDistinguished. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Campbell isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Campbell isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Renal Cell Carcinoma (RCC)Dr. Campbell isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Upper Tract Urothelial Carcinoma (UTUC)Dr. Campbell isDistinguished. Learn about Upper Tract Urothelial Carcinoma (UTUC).
- Urothelial CancerDr. Campbell isDistinguished. Learn about Urothelial Cancer.
- Wilms TumorDr. Campbell isDistinguished. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Campbell isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Teratoma of the MediastinumDr. Campbell isAdvanced. Learn about Teratoma of the Mediastinum.
- Testicular CancerDr. Campbell isAdvanced. Learn about Testicular Cancer.
- Experienced
- Desmoplastic Small Round Cell TumorDr. Campbell isExperienced. Learn about Desmoplastic Small Round Cell Tumor.
- Familial Prostate CancerDr. Campbell isExperienced. Learn about Familial Prostate Cancer.
- Glomus Jugulare TumorDr. Campbell isExperienced. Learn about Glomus Jugulare Tumor.
- Hereditary NeuroblastomaDr. Campbell isExperienced. Learn about Hereditary Neuroblastoma.
- Hereditary Paraganglioma-Pheochromocytoma Syndrome
- Lymphofollicular HyperplasiaDr. Campbell isExperienced. Learn about Lymphofollicular Hyperplasia.
- Mediastinal TumorDr. Campbell isExperienced. Learn about Mediastinal Tumor.
- MelanomaDr. Campbell isExperienced. Learn about Melanoma.
- Metastatic Brain TumorDr. Campbell isExperienced. Learn about Metastatic Brain Tumor.
- Metastatic Pleural TumorDr. Campbell isExperienced. Learn about Metastatic Pleural Tumor.
- NeuroblastomaDr. Campbell isExperienced. Learn about Neuroblastoma.
- Neuroendocrine TumorDr. Campbell isExperienced. Learn about Neuroendocrine Tumor.
- Penile CancerDr. Campbell isExperienced. Learn about Penile Cancer.
- Posterior Fossa TumorDr. Campbell isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Campbell isExperienced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Prostate CancerDr. Campbell isExperienced. Learn about Prostate Cancer.
- Pseudomyxoma PeritoneiDr. Campbell isExperienced. Learn about Pseudomyxoma Peritonei.
- Retroperitoneal LiposarcomaDr. Campbell isExperienced. Learn about Retroperitoneal Liposarcoma.
- Testicular Yolk Sac TumorDr. Campbell isExperienced. Learn about Testicular Yolk Sac Tumor.